{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:42:24Z","timestamp":1777563744566,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study aimed to compare the diagnostic efficiency of Ovarian-Adnexal Reporting and Data System (O-RADS) and doctors\u2019 subjective judgment in diagnosing the malignancy risk of adnexal masses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was an analysis of 616 adnexal masses between 2017 and 2020. The clinical findings, preoperative ultrasound images, and pathological diagnosis were recorded. Each adnexal mass was evaluated by doctors\u2019 subjective judgment and O-RADS by two senior doctors and two junior doctors. A mass with an O-RADS grade of 1 to 3 was a benign tumor, and a mass with an O-RADS grade of 4\u20135 was a malignant tumor. All outcomes were compared with the pathological diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 616 adnexal masses, 469 (76.1%) were benign, and 147 (23.9%) were malignant. There was no difference between the area under the curve of O-RADS and the subjective judgment for junior doctors (0.83 (95% CI: 0.79\u20130.87) vs. 0.79 (95% CI: 0.76\u20130.83), <jats:italic>p<\/jats:italic>\u2009=\u20090.0888). The areas under the curve of O-RADS and subjective judgment were equal for senior doctors (0.86 (95% CI: 0.83\u20130.89) vs. 0.86 (95% CI: 0.83\u20130.90), <jats:italic>p<\/jats:italic>\u2009=\u20090.8904). O-RADS had much higher sensitivity than the subjective judgment in detecting malignant tumors for junior doctors (84.4% vs. 70.1%) and senior doctors (91.2% vs. 81.0%). In the subgroup analysis for detecting the main benign lesions of the mature cystic teratoma and ovarian endometriosic cyst, the junior doctors\u2019 diagnostic accuracy was obviously worse than the senior doctors\u2019 on using O-RADS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>O-RADS had excellent performance in predicting malignant adnexal masses. It could compensate for the lack of experience of junior doctors to a certain extent. Better performance in discriminating various benign lesions should be expected with some complement.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12880-023-01153-9","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T14:02:41Z","timestamp":1700488961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparison of the diagnostic efficiency between the O-RADS US risk stratification system and doctors\u2019 subjective judgment"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5795-8277","authenticated-orcid":false,"given":"Shan","family":"Zhou","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5630-6912","authenticated-orcid":false,"given":"Yuyang","family":"Guo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3283-888X","authenticated-orcid":false,"given":"Lieming","family":"Wen","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4203-9985","authenticated-orcid":false,"given":"Jieyu","family":"Liu","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3683-304X","authenticated-orcid":false,"given":"Yaqian","family":"Fu","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2326-6288","authenticated-orcid":false,"given":"Fang","family":"Xu","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6548-3264","authenticated-orcid":false,"given":"Minghui","family":"Liu","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7185-292X","authenticated-orcid":false,"given":"Baihua","family":"Zhao","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,11,20]]},"reference":[{"issue":"6","key":"1153_CR1","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ajog.2017.07.019","volume":"217","author":"JS Abramowicz","year":"2017","unstructured":"Abramowicz JS, Timmerman D. Ovarian mass-differentiating benign from malignant: the value of the international ovarian tumor analysis ultrasound rules. Am J Obstet Gynecol. 2017;217(6):652\u201360.","journal-title":"Am J Obstet Gynecol"},{"issue":"1\u20132","key":"1153_CR2","first-page":"41","volume":"85","author":"M Kossa\u00ef","year":"2018","unstructured":"Kossa\u00ef M, Leary A, Scoazec J, Genestie C. Ovarian cancer: a heterogeneous disease. Pathology. 2018;85(1\u20132):41\u20139.","journal-title":"Pathology."},{"issue":"12","key":"1153_CR3","doi-asserted-by":"publisher","first-page":"647","DOI":"10.5603\/GP.a2017.0116","volume":"88","author":"J Koneczny","year":"2017","unstructured":"Koneczny J, Czekierdowski A, Florczak M, Poziemski P, Stachowicz N, Borowski D. The use of sonographic subjective tumor assessment, IOTA logistic regression model 1, IOTA simple rules and GI-RADS system in the preoperative prediction of malignancy in women with adnexal masses. Ginekol Pol. 2017;88(12):647\u201353.","journal-title":"Ginekol Pol"},{"issue":"10","key":"1153_CR4","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1471-0528.1990.tb02448.x","volume":"97","author":"I Jacobs","year":"1990","unstructured":"Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol. 1990;97(10):922\u20139.","journal-title":"Br J Obstet Gynaecol"},{"issue":"8","key":"1153_CR5","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1471-0528.1996.tb09882.x","volume":"103","author":"S Tingulstad","year":"1996","unstructured":"Tingulstad S, Hagen B, Skjeldestad FE, Onsrud M, Kiserud T, Halvorsen T, et al. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol. 1996;103(8):826\u201331.","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"1153_CR6","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/00006250-199903000-00028","volume":"93","author":"S Tingulstad","year":"1999","unstructured":"Tingulstad S, Hagen B, Skjeldestad FE, Halvorsen T, Nustad K, Onsrud M. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. Obstet Gynecol. 1999;93(3):448\u201352.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"1153_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejogrb.2009.02.048","volume":"144","author":"Y Yamamoto","year":"2009","unstructured":"Yamamoto Y, Yamada R, Oguri H, Maeda N, Fukaya T. Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses. Eur J Obstet Gynecol Reprod Biol. 2009;144(2):163\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"1153_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13048-020-00643-6","volume":"13","author":"A Hada","year":"2020","unstructured":"Hada A, Han LP, Chen Y, Hu QH, Yuan YD, Liu LY. Comparison of the predictive performance of risk of malignancy indexes 1-4, HE4 and risk of malignancy algorithm in the triage of adnexal masses. J Ovarian Res. 2020;13(1):46.","journal-title":"J Ovarian Res"},{"issue":"5","key":"1153_CR9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1046\/j.1469-0705.2000.00287.x","volume":"16","author":"D Timmerman","year":"2000","unstructured":"Timmerman D, Valentin L, Bourne TH, Collins WP, Verrelst H, Vergote I. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the international ovarian tumor analysis (IOTA) group. Ultrasound Obstet Gynecol. 2000;16(5):500\u20135.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"1153_CR10","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/uog.5365","volume":"31","author":"D Timmerman","year":"2008","unstructured":"Timmerman D, Testa AC, Bourne T, Ameye L, Jurkovic D, Van Holsbeke C, et al. Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol. 2008;31(6):681\u201390.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"34","key":"1153_CR11","doi-asserted-by":"publisher","first-page":"8794","DOI":"10.1200\/JCO.2005.01.7632","volume":"23","author":"D Timmerman","year":"2005","unstructured":"Timmerman D, Testa AC, Bourne T, Ferrazzi E, Ameye L, Konstantinovic ML, et al. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the international ovarian tumor analysis group. J Clin Oncol. 2005;23(34):8794\u2013801.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1153_CR12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/uog.9012","volume":"38","author":"F Amor","year":"2011","unstructured":"Amor F, Alc\u00e1zar JL, Vaccaro H, Le\u00f3n M, Iturra A. GI-RADS reporting system for ultrasound evaluation of adnexal masses in clinical practice: a prospective multicenter study. Ultrasound Obstet Gynecol. 2011;38(4):450\u20135.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"10","key":"1153_CR13","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.jacr.2018.07.004","volume":"15","author":"RF Andreotti","year":"2018","unstructured":"Andreotti RF, Timmerman D, Benacerraf BR, Bennett GL, Bourne T, Brown DL, et al. Ovarian-adnexal reporting lexicon for ultrasound: a white paper of the ACR ovarian-adnexal reporting and data system committee. J Am Coll Radiol. 2018;15(10):1415\u201329.","journal-title":"J Am Coll Radiol"},{"issue":"1","key":"1153_CR14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1148\/radiol.2019191150","volume":"294","author":"RF Andreotti","year":"2020","unstructured":"Andreotti RF, Timmerman D, Strachowski LM, Froyman W, Benacerraf BR, Bennett GL, et al. O-RADS US risk stratification and management system: a consensus guideline from the ACR ovarian-adnexal reporting and data system committee. Radiology. 2020;294(1):168\u201385.","journal-title":"Radiology."},{"key":"1153_CR15","doi-asserted-by":"publisher","first-page":"c6839","DOI":"10.1136\/bmj.c6839","volume":"341","author":"D Timmerman","year":"2010","unstructured":"Timmerman D, Ameye L, Fischerova D, Epstein E, Melis GB, Guerriero S, et al. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. BMJ. 2010;341:c6839.","journal-title":"BMJ"},{"issue":"2","key":"1153_CR16","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1158\/1078-0432.CCR-08-0113","volume":"15","author":"C Van Holsbeke","year":"2009","unstructured":"Van Holsbeke C, Van Calster B, Testa AC, Domali E, Lu C, Van Huffel S, et al. Prospective internal validation of mathematical models to predict malignancy in adnexal masses: results from the international ovarian tumor analysis study. Clin Cancer Res. 2009;15(2):684\u201391.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"1153_CR17","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/bjc.2014.333","volume":"111","author":"A Testa","year":"2014","unstructured":"Testa A, Kaijser J, Wynants L, Fischerova D, Van Holsbeke C, Franchi D, et al. Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study. Br J Cancer. 2014;111(4):680\u20138.","journal-title":"Br J Cancer"},{"issue":"1","key":"1153_CR18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-2006-933605","volume":"27","author":"Education and Practical Standards Committee, European Federation of Societies for Ultrasound in Medicine and Biology","year":"2006","unstructured":"Education and Practical Standards Committee, European Federation of Societies for Ultrasound in Medicine and Biology. Minimum training recommendations for the practice of medical ultrasound. Ultraschall Med. 2006;27(1):79\u2013105.","journal-title":"Ultraschall Med"},{"issue":"Suppl 1","key":"1153_CR19","first-page":"S161","volume":"95","author":"AP Heintz","year":"2006","unstructured":"Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, et al. Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological Cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S161\u201392.","journal-title":"Int J Gynaecol Obstet"},{"key":"1153_CR20","first-page":"1","volume-title":"WHO classification of tumours: female genital tumours","author":"WHO Classification of Tumours Editorial Board","year":"2020","unstructured":"WHO Classification of Tumours Editorial Board. WHO classification of tumours: female genital tumours. Lyon (France): IARC Publications; 2020. p. 1\u2013632."},{"issue":"3","key":"1153_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.14366\/usg.21237","volume":"41","author":"YY Guo","year":"2022","unstructured":"Guo YY, Zhao BH, Zhou S, Wen LM, Liu JY, Fu YQ, et al. A comparison of the diagnostic performance of the O-RADS, RMI4, IOTA LR2, and IOTA SR systems by senior and junior doctors. Ultrasonography. 2022;41(3):511\u2013518.22.","journal-title":"Ultrasonography."},{"issue":"6","key":"1153_CR22","doi-asserted-by":"publisher","first-page":"756.e1","DOI":"10.1016\/j.ajog.2016.07.024","volume":"215","author":"D Franchi","year":"2016","unstructured":"Franchi D, Boveri S, Radice D, Portuesi R, Zanagnolo V, Colombo N, et al. Ultrasonographic diagnosis and longitudinal follow-up of recurrences after conservative surgery for borderline ovarian tumors. Am J Obstet Gynecol. 2016;215(6):756.e1\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1153_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3892\/mco.2022.2554","volume":"17","author":"VA Capozzi","year":"2022","unstructured":"Capozzi VA, Cianci S, Scarpelli E, Monfardini L, Cianciolo A, Barresi G, et al. Predictive features of borderline ovarian tumor recurrence in patients with childbearing potential undergoing conservative treatment. Mol Clin Oncol. 2022;17(1):121.","journal-title":"Mol Clin Oncol"},{"issue":"6","key":"1153_CR24","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/uog.17414","volume":"50","author":"F Moro","year":"2017","unstructured":"Moro F, Baima Poma C, Zannoni GF, Vidal Urbinati A, Pasciuto T, Ludovisi M, et al. Imaging in gynecological disease (12): clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors. Ultrasound Obstet Gynecol. 2017;50(6):788\u201399.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"1153_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/uog.17222","volume":"50","author":"F Moro","year":"2017","unstructured":"Moro F, Zannoni GF, Arciuolo D, Pasciuto T, Amoroso S, Mascilini F, et al. Imaging in gynecological disease (11): clinical and ultrasound features of mucinous ovarian tumors. Ultrasound Obstet Gynecol. 2017;50(2):261\u201370.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1153_CR26","doi-asserted-by":"publisher","first-page":"951472","DOI":"10.3389\/fsurg.2022.951472","volume":"9","author":"LN Niu","year":"2023","unstructured":"Niu LN, Wang WB, Xu YJ, Xu T, Sun JL, Lv WQ, et al. The value of ultrasonography combined with carbohydrate antigen 125 and 19-9 detection in the diagnosis of borderline ovarian tumors and prediction of recurrence. Front Surg. 2023;9:951472.","journal-title":"Front Surg"},{"issue":"5","key":"1153_CR27","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/uog.17392","volume":"50","author":"A Di Legge","year":"2017","unstructured":"Di Legge A, Pollastri P, Mancari R, Ludovisi M, Mascilini F, Franchi D, et al. Clinical and ultrasound characteristics of surgically removed adnexal lesions with largest diameter \u2264 2.5 cm: a pictorial essay. Ultrasound Obstet Gynecol. 2017;50(5):648\u201356.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"1153_CR28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/uog.26212","volume":"62","author":"M Bruno","year":"2023","unstructured":"Bruno M, Capanna G, Di Florio C, Sollima L, Guido M, Ludovisi M. Sonographic characteristics of ovarian Leydig cell tumor. Ultrasound Obstet Gynecol. 2023;62(3):441\u20132.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9","key":"1153_CR29","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1093\/humrep\/des231","volume":"27","author":"A Fagotti","year":"2012","unstructured":"Fagotti A, Ludovisi M, Blasis D, Virgilio B, Di Legge A, Mascilini F, et al. The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: a pilot study. Hum Reprod. 2012;27(9):2676\u201383.","journal-title":"Hum Reprod"},{"issue":"3","key":"1153_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/uog.20283","volume":"54","author":"IE Timor-Tritsch","year":"2019","unstructured":"Timor-Tritsch IE, Foley CE, Brandon C, Yoon E, Ciaffarrano J, Monteagudo A, et al. New sonographic marker of borderline ovarian tumor: microcystic pattern of papillae and solid components. Ultrasound Obstet Gynecol. 2019;54(3):395\u2013402.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9","key":"1153_CR31","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/jcu.22266","volume":"43","author":"M Ludovisi","year":"2015","unstructured":"Ludovisi M, Foo XL, Mainenti S, Carla Testa A, Arora R, Jurkovic D. Ultrasound diagnosis of serous surface papillary borderline ovarian tumor: a case series with a review of the literature. J Clin Ultrasound. 2015;43(9):573\u20137.","journal-title":"J Clin Ultrasound"},{"key":"1153_CR32","doi-asserted-by":"publisher","unstructured":"Wang D, Su N, Wang R, Zhang L, Qi Z, Liu Z, et al. Serous surface papillary borderline ovarian tumors: sonographic features with clinicopathological correlation. Ultrasound Obstet Gynecol. 2023; https:\/\/doi.org\/10.1002\/uog.27454. Online ahead of print","DOI":"10.1002\/uog.27454"},{"issue":"7","key":"1153_CR33","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3390\/diagnostics13071307","volume":"13","author":"M Pelayo","year":"2023","unstructured":"Pelayo M, Pelayo-Delgado I, Sancho-Sauco J, Sanchez-Zurdo J, Abarca-Martinez L, Corraliza-Gal\u00e1n V, et al. Comparison of ultrasound scores in differentiating between benign and malignant adnexal masses. Diagnostics (Basel). 2023;13(7):1307.","journal-title":"Diagnostics (Basel)"},{"issue":"13","key":"1153_CR34","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.3390\/diagnostics13132152","volume":"13","author":"M Pelayo","year":"2023","unstructured":"Pelayo M, Sancho-Sauco J, Sanchez-Zurdo J, Abarca-Martinez L, Borrero-Gonzalez C, Sainz-Bueno JA, et al. Ultrasound features and ultrasound scores in the differentiation between benign and malignant adnexal masses. Diagnostics (Basel). 2023;13(13):2152.","journal-title":"Diagnostics (Basel)"},{"issue":"13","key":"1153_CR35","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1056\/NEJMra1810764","volume":"382","author":"KT Zondervan","year":"2020","unstructured":"Zondervan KT, Becker CM, Stacey AM. Endometriosis. N Engl J Med. 2020;382(13):1244\u201356.","journal-title":"N Engl J Med"},{"issue":"1","key":"1153_CR36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s12905-021-01545-5","volume":"21","author":"RK Dimitrios","year":"2021","unstructured":"Dimitrios RK, Nicolas S, Georgios NK, Evangelia M, Eleftherios PS, Markus E, et al. Treatment of endometriosis: a review with comparison of 8 guidelines. BMC Womens Health. 2021;21(1):397.","journal-title":"BMC Womens Health"},{"issue":"1","key":"1153_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00404-019-05358-8","volume":"301","author":"M Kr\u00e1l\u00ed\u010dkov\u00e1","year":"2020","unstructured":"Kr\u00e1l\u00ed\u010dkov\u00e1 M, Lagan\u00e0 AS, Ghezzi F, Vetvicka V. Endometriosis and risk of ovarian cancer: what do we know? Arch Gynecol Obstet. 2020;301(1):1\u201310.","journal-title":"Arch Gynecol Obstet"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-023-01153-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-023-01153-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-023-01153-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T14:20:52Z","timestamp":1700490052000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-023-01153-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,20]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1153"],"URL":"https:\/\/doi.org\/10.1186\/s12880-023-01153-9","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,20]]},"assertion":[{"value":"30 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of Second Xiangya Hospital of Central South University (No. 2021\u201338) and conducted according to the principles of the Declaration of Helsinki. The need for the patient\u2019s informed consent was waived by the Medical Ethics Committee of Second Xiangya Hospital of Central South University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"190"}}